BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9143261)

  • 1. Meningioangiomatosis is associated with neurofibromatosis 2 but not with somatic alterations of the NF2 gene.
    Stemmer-Rachamimov AO; Horgan MA; Taratuto AL; Munoz DG; Smith TW; Frosch MP; Louis DN
    J Neuropathol Exp Neurol; 1997 May; 56(5):485-9. PubMed ID: 9143261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cases of Mixed Schwannoma-Meningioma With and Without Neurofibromatosis 2 with Emphasis on Tumorigenesis.
    Rajeswarie RT; Mallik D; Rudrappa S; Gopal S
    Int J Surg Pathol; 2024 May; 32(3):511-514. PubMed ID: 37487199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2.
    Sarkar S; Throckmorton W; Bingham R; Msaouel P; Genovese G; Slopis J; Rao P; Sadighi Z; Herzog CE
    Curr Oncol; 2023 Mar; 30(3):3355-3365. PubMed ID: 36975468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.
    Blakeley JO; Plotkin SR
    Neuro Oncol; 2016 May; 18(5):624-38. PubMed ID: 26851632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningiomas in patients with neurofibromatosis type 2 predominantly comprise 'immunogenic subtype' tumours characterised by macrophage infiltration.
    Teranishi Y; Miyawaki S; Nakatochi M; Okano A; Ohara K; Hongo H; Ishigami D; Sakai Y; Shimada D; Takayanagi S; Ikemura M; Komura D; Katoh H; Mitsui J; Morishita S; Ushiku T; Ishikawa S; Nakatomi H; Saito N
    Acta Neuropathol Commun; 2023 Sep; 11(1):156. PubMed ID: 37752594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of MicroRNA Expression Depending on the Presence or Absence of Meningioma in Patients with Neurofibromatosis Type 2: A Secondary Analysis.
    Imura T; Mitsuhara T; Horie N
    Neurol Med Chir (Tokyo); 2024 Mar; 64(3):116-122. PubMed ID: 38267057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study.
    Baser ME; Kuramoto L; Joe H; Friedman JM; Wallace AJ; Gillespie JE; Ramsden RT; Evans DG
    Am J Hum Genet; 2004 Aug; 75(2):231-9. PubMed ID: 15190457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive histomolecular characterization of meningioangiomatosis: Further evidence for a precursor neoplastic lesion.
    Tauziède-Espariat A; Masliah-Planchon J; Sievers P; Sahm F; Dangouloff-Ros V; Boddaert N; Hasty L; Aboubakr O; Métais A; Chrétien F; Roux A; Pallud J; Blauwblomme T; Beccaria K; Bourdeaut F; Puget S; Varlet P
    Brain Pathol; 2024 Apr; ():e13259. PubMed ID: 38565263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.
    Banerjee J; Friedman JM; Klesse LJ; Yohay KH; Jordan JT; Plotkin SR; Allaway RJ; Blakeley JO
    Genet Med; 2023 Feb; 25(2):100324. PubMed ID: 36565307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaicism in neurofibromatosis type 2: an update of risk based on uni/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification.
    Evans DG; Ramsden RT; Shenton A; Gokhale C; Bowers NL; Huson SM; Pichert G; Wallace A
    J Med Genet; 2007 Jul; 44(7):424-8. PubMed ID: 17307835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of tethered cord syndrome in neurofibromatosis types 1 and 2 pediatric patients: a population-level analysis.
    Bhanja D; Freedman Z; Sciscent BY; Moeckel C; Daggubati L; Rizk E
    Childs Nerv Syst; 2024 Jun; 40(6):1821-1825. PubMed ID: 38451296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brainstem ischemic syndrome in juvenile NF2.
    Henson JW; Benkers T; McCormick C
    Neurol Genet; 2020 Aug; 6(4):e446. PubMed ID: 32637630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ptosis, Visual Blurring, and Multiple Cranial Nerve Tumors: Do We Know the Culprit.
    Singanamalla B; Vyas S; Madaan P; Saini L
    Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):5361-5363. PubMed ID: 36742908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Publisher Correction to: Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents.
    Wagener K; Beckhaus J; Boekhoff S; Friedrich C; Müller HL
    J Neurooncol; 2023 Sep; 164(2):503. PubMed ID: 37644230
    [No Abstract]   [Full Text] [Related]  

  • 15. Nævo-neurofibromatosis.
    Lightwood R
    Proc R Soc Med; 1932 Oct; 25(12):1738. PubMed ID: 19988976
    [No Abstract]   [Full Text] [Related]  

  • 16. Case report: Meningioma associated with meningioangiomatosis mimicking invasive meningioma.
    Ge R; Yang J; Yin X; Wang J
    Front Neurol; 2023; 14():1200827. PubMed ID: 37448750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Alterations in Meningioangiomatosis Causing Epilepsy.
    Dono A; Pothiawala AZ; Lewis CT; Bhattacharjee MB; Ballester LY; Tandon N
    J Neuropathol Exp Neurol; 2021 Nov; 80(11):1043–1051. PubMed ID: 34580720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the CNS manifestations of neurofibromatosis type 2.
    Coy S; Rashid R; Stemmer-Rachamimov A; Santagata S
    Acta Neuropathol; 2020 Apr; 139(4):643-665. PubMed ID: 31161239
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.